Native opportunities to stop hypertension: study protocol for a randomized controlled trial among urban American
Ka'imi Sinclair1, Cassandra J Nguyen2, Marianna S Wetherill3
1Institute for Research and Education to Advance Community Health, Washington State University, Seattle, WA, United States.
Insights
Native Opportunities to Stop Hypertension (NOSH) is a diet intervention for American Indian and Alaska Native (AI/AN) adults with hypertension. This study assessed its effectiveness in lowering systolic blood pressure (BP) and improving cardiovascular disease (CVD) risk factors.
Area of Science:
- Cardiovascular Disease Research
- Nutritional Science
- Public Health Interventions
Background:
- American Indian and Alaska Native (AI/AN) adults face higher cardiovascular disease (CVD) morbidity and mortality, often linked to hypertension (HTN).
- Dietary Approaches to Stop Hypertension (DASH) is effective for CVD prevention, but its impact on AI/AN populations requires specific investigation due to unique social determinants of health.
Purpose of the Study:
- To evaluate the effectiveness of the Native Opportunities to Stop Hypertension (NOSH) intervention on reducing systolic blood pressure (BP) in urban AI/AN adults.
- To assess the impact of the NOSH intervention on modifiable CVD risk factors and dietary intake within this population.
Main Methods:
- A randomized controlled trial comparing an adapted DASH intervention (NOSH) with a control group among AI/AN adults (≥18 years) diagnosed with HTN and elevated systolic BP (≥130 mmHg).
- The NOSH intervention involved eight weekly telenutrition counseling sessions with registered dietitians, focusing on DASH eating principles, with weekly financial incentives for food purchases.
- Participants received assessments at baseline, 8 weeks, and 12 weeks post-intervention; a subsample underwent extended follow-up to 9 months.
Main Results:
- The study assessed the primary outcome of systolic blood pressure (BP).
- Secondary outcomes included changes in modifiable CVD risk factors, heart disease and stroke risk scores, and dietary intake patterns.
Conclusions:
- The NOSH study is one of the first randomized controlled trials to examine a diet-based intervention for hypertension in urban AI/AN adults.
- Findings from NOSH have the potential to guide future clinical strategies aimed at reducing blood pressure and improving cardiovascular health in AI/AN communities.
Introduction:
American Indian and Alaska Native (AI/AN) adults experience disproportionate cardiovascular disease (CVD) morbidity and mortality compared to other races, which may be partly attributable to higher burden of hypertension (HTN). Dietary Approaches to Stop Hypertension (DASH) is a high-impact therapeutic dietary intervention for primary and secondary prevention of CVD that can contribute to significant decreases in systolic blood pressure (BP). However, DASH-based interventions have not been tested with AI/AN adults, and unique social determinants of health warrant independent trials. This study will assess the effectiveness of a DASH-based intervention, called Native Opportunities to Stop Hypertension (NOSH), on systolic BP among AI/AN adults in three urban clinics.
Methods:
NOSH is a randomized controlled trial to test the effectiveness of an adapted DASH intervention compared to a control condition. Participants will be aged ≥18 years old, self-identify as AI/AN, have physician-diagnosed HTN, and have elevated systolic BP (≥ 130 mmHg). The intervention includes eight weekly, tailored telenutrition counseling sessions with a registered dietitian on DASH eating goals. Intervention participants will be provided $30 weekly and will be encouraged to purchase DASH-aligned foods. Participants in the control group will receive printed educational materials with general information about a low-sodium diet and eight weekly $30 grocery orders. All participants will complete assessments at baseline, after the 8-week intervention, and again 12 weeks post-baseline. A sub-sample of intervention participants will complete an extended support pilot study with assessments at 6- and 9-months post-baseline. The primary outcome is systolic BP. Secondary outcomes include modifiable CVD risk factors, heart disease and stroke risk scores, and dietary intake.
Discussion:
NOSH is among the first randomized controlled trials to test the impact of a diet-based intervention on HTN among urban AI/AN adults. If effective, NOSH has the potential to inform clinical strategies to reduce BP among AI/AN adults.
Clinical Trials Registration:
https://clinicaltrials.gov/ct2/show/NCT02796313, Identifier NCT02796313.
More Related Videos
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Pre-Procedural Guidelines for Assessing Blood Pressure
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction


